{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:26:16Z","timestamp":1778689576402,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1002\/jps.20597","type":"journal-article","created":{"date-parts":[[2006,3,16]],"date-time":"2006-03-16T22:46:50Z","timestamp":1142549210000},"page":"985-997","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacokinetics and Therapeutic Effects of Oltipraz after Consecutive or Intermittent Oral Administration in Rats with Liver Cirrhosis Induced by Dimethylnitrosamine"],"prefix":"10.1016","volume":"95","author":[{"given":"Soo K.","family":"Bae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taekrho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inchul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang G.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20597_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0163-7258(97)00164-2","article-title":"Chemopreventive activity of oltipraz","volume":"78","author":"Clapper","year":"1998","journal-title":"Pharmacol Ther"},{"key":"10.1002\/jps.20597_bb0015","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1096\/fj.02-0406fje","article-title":"Oltipraz regenerates cirrhotic liver through CCAAT\/enhancer binding protein-mediated stellate cell inactivation","volume":"16","author":"Kang","year":"2002","journal-title":"FASEB J"},{"key":"10.1002\/jps.20597_bb0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/bdd.437","article-title":"Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits, and dogs, and prediction of human pharmacokinetics","volume":"26","author":"Bae","year":"2005","journal-title":"Biopharm Drug Dispos"},{"key":"10.1002\/jps.20597_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/bdd.439","article-title":"Hepatic and intestinal first-pass effects of oltipraz in rats","volume":"26","author":"Bae","year":"2005","journal-title":"Biopharm Drug Dispos"},{"key":"10.1002\/jps.20597_bb0030","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.510280627","article-title":"Endotoxin suppresses the oltipraz-mediated induction of major hepatic glutathione transferases and cytochromes P450 in the rat","volume":"28","author":"Maheo","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/jps.20597_bb0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijpharm.2004.02.004","article-title":"Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine","volume":"275","author":"Bae","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20597_bb0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0168-8278(85)80747-9","article-title":"A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rats","volume":"1","author":"Jenkins","year":"1985","journal-title":"J Hepatol"},{"key":"10.1002\/jps.20597_bb0045","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0168-8278(87)80570-6","article-title":"A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat","volume":"6","author":"Jezequel","year":"1987","journal-title":"J Hepatol"},{"key":"10.1002\/jps.20597_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01061772","article-title":"Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition","volume":"21","author":"Kim","year":"1993","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1002\/jps.20597_bb0055","first-page":"133","article-title":"Determination of a chemopreventive agent, oltipraz, in rat plasma and urine by high-performance liquid chromatography","volume":"110","author":"Bae","year":"2001","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1002\/jps.20597_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0378-4347(92)80577-D","article-title":"Determination of oltipraz in serum by high-performance liquid chromatography with optical absorbance and mass spectrometric detection","volume":"584","author":"Christensen","year":"1992","journal-title":"J Chromatogr"},{"key":"10.1002\/jps.20597_bb0065","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01062108","article-title":"Critical evaluation of the potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve","volume":"6","author":"Chiou","year":"1978","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1002\/jps.20597_bb0070","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1982"},{"key":"10.1002\/jps.20597_bb0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jps.2600690125","article-title":"New calculation method of mean total body clearance of drugs and its application to rational dosage regimens","volume":"69","author":"Chiou","year":"1980","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20597_bb0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF01061729","article-title":"Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects","volume":"5","author":"Eatman","year":"1977","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1002\/jps.20597_bb0085","first-page":"333","article-title":"Stability, blood partition and protein binding of an antifibrotic agent, oltipraz","volume":"109","author":"Bu","year":"2001","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1002\/jps.20597_bb0090","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1211\/0022357055704","article-title":"Effects of enzyme inducers and inhibitors on the pharmacokinetics of oltipraz in rats","volume":"57","author":"Bae","year":"2005","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.20597_bb0095","first-page":"1431","article-title":"Disposition of [14C]oltipraz in animals. Pharmacokinetics in mice, rats and monkeys. Comparison of the biotransformation in the infected mouse and in the schistosomes","volume":"35","author":"Heusse","year":"1985","journal-title":"Arzneim Forsch\/Drug Res"},{"key":"10.1002\/jps.20597_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpt1975184377","article-title":"Commentary: a physiological approach to hepatic drug clearance","volume":"18","author":"Wilkinson","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.20597_bb0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0009-9120(01)00242-9","article-title":"Erythrocyte creatine as a marker of excessive erythrocyte destruction due to hypersplenism in patients with liver cirrhosis","volume":"34","author":"Jiao","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1002\/jps.20597_bb0110","first-page":"85","article-title":"Hypersplenism in liver cirrhosis","volume":"52","author":"Tsuji","year":"1994","journal-title":"Nippon Rinsho"},{"key":"10.1002\/jps.20597_bb0115","first-page":"365","article-title":"Splenomegaly and plasma lipids","volume":"55","author":"Wysocki","year":"1998","journal-title":"Przegl Lek"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491632007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491632007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T11:25:06Z","timestamp":1555500306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235491632007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S002235491632007X"],"URL":"https:\/\/doi.org\/10.1002\/jps.20597","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}